'अभी उसे और मैच खेलने चाहिए...', वैभव की उपकप्तानी पर सचिन तेंदुलकर ने उठाए सवाल, गांगुली-धोनी पर भी दिया बयान

The insurer says its existing distribution cost controls offer protection, even as it prepares to align certain products with revised norms

The company reported a net profit of ₹114.54 crore in Q2FY27, down from ₹119.66 crore in Q2FY26.

This initiative succeeded in breaking the deadlock between sugarcane farmers and factories, allowing commencement of operations in sugar factories

Pharma stocks on a roll: Symbiotec Pharmalab, Windlas Biotech, Sai Life Sciences, Alembic Pharmaceuticals and Fermation Biotech were up in the range of 9-20% on Friday.